Skip to main content
. 2018 Jun 27;13:2041–2047. doi: 10.2147/COPD.S163243

Table 2.

Comparison between subjects with and without bronchiectasis

Variables COPD with bronchiectasis, n=140 COPD without bronchiectasis, n=1,599 P-value
Age, years 68.3±9.1 68.6±9.8 0.497a
Male, n (%) 102 (72.9) 1,285 (80.4) 0.034b
BMI, kg/m2 23.4±4.0 23.4±4.0 0.872c
Smokers, n (%) 96 (68.6) 1,192 (74.5) 0.099b
Smoking history, pack-years 29.1±29.1 31.6±30.2 0.369a
Blood tests
 ALB, g/L 36.7±5.5 37.7±5.3 0.046a
 ESR, mm/h 23.1±19.6 24.8±23.6 0.888a
 Fib, g/L 3.7±1.3 3.6±2.1 0.231a
PFT
 FVC, L 2.2±0.8 2.7±0.9 <0.001a
 FEV1, L 1.1±0.5 1.5±0.7 <0.001a
 FEV1 % predicted 41.9±17.9 53.8±22.0 <0.001a
 FEV1/FVC% 49.5±12.2 55.4±12.5 <0.001a
Comorbidity, n (%)
 Tuberculosis 11 (7.9) 185 (11.6) 0.183b
 Ischemic heart disease 31 (22.1) 390 (24.4) 0.552b
 Pulmonary 9 (6.4) 38 (2.4) 0.005b
hypertension
 Hypertension 38 (27.1) 499 (31.2) 0.318b
 Cor pulmonale 33 (23.6) 257 (16.1) 0.022b
 Diabetes mellitus 18 (12.9) 147 (9.2) 0.156b
%LAA-950 15.0±12.0 13.4±13.4 0.011a

Notes: Data are presented as mean ± SD for continuous variables and percentage for categorical variables.

a

Analysis by Mann–Whitney U-test.

b

Analysis by chi-square test.

c

Analysis by Student’s t-test.

Abbreviations: ALB, albumin; BMI, body mass index; ESR, erythrocyte sedimentation rate; Fib, fibrinogen; %LAA-950, percentage of lung voxels with CT attenuation value below −950 HU; PFT, pulmonary function test.